OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Nesrin M. Hasan, Nita Ahuja
Cancers (2019) Vol. 11, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Dongfang Jiang, Tingting Li, Caixia Guo, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 31

Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy
Fang-Lin Zhang, Da‐Qiang Li
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12815-12815
Open Access | Times Cited: 31

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
L. Paige Ferguson, Jovylyn Gatchalian, Matthew L. McDermott, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13

Leveraging Epigenetic Alterations in Pancreatic Ductal Adenocarcinoma for Clinical Applications
Jörg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Seminars in Cancer Biology (2025)
Open Access

Unconventional receptor functions and location-biased signaling of the lactate GPCR in the nucleus
Mohammad Ali Mohammad Nezhady, Gaël Cagnone, Emmanuel Bajon, et al.
Life Science Alliance (2025) Vol. 8, Iss. 4, pp. e202503226-e202503226
Open Access

Long non-coding RNAs: the tentacles of chromatin remodeler complexes
Bernadette Neve, Nicolas Jonckheere, Audrey Vincent, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 4, pp. 1139-1161
Open Access | Times Cited: 28

Inflammatory factors and risk of lung adenocarcinoma: a Mendelian randomization study mediated by blood metabolites
Zheng Ding, Juan Chen, Bohan Li, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3

ISWI chromatin remodeling complexes recruit NSD2 and H3K36me2 in pericentromeric heterochromatin
Naoki Gotō, Kazuma Suke, Nao Yonezawa, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 8
Open Access | Times Cited: 2

Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states
Kaichun Li, Enrico Girardi, Felix Kartnig, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 651-664
Open Access | Times Cited: 14

Genomic analysis reveals HDAC1 regulates clinically relevant transcriptional programs in Pancreatic cancer
Carter Wright, Emily R. Gordon, Sara J. Cooper
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
Elena-Georgiana Dobre, Carolina Constantin, Marieta Costache, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 901-901
Open Access | Times Cited: 12

Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8

Spectroscopic screening of pancreatic cancer
K Szymoński, Ewelina Lipiec, Kamila Sofińska, et al.
Clinical Spectroscopy (2021) Vol. 3, pp. 100016-100016
Open Access | Times Cited: 11

Advances in the Role of Epigenetics in Homocysteine-Related Diseases
Chengyan Wu, Xulei Duan, Xuehui Wang, et al.
Epigenomics (2023) Vol. 15, Iss. 15, pp. 769-795
Closed Access | Times Cited: 4

Gene amplification of chromatin remodeling factor SMARCC2 and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma
Naomi Magarifuchi, Takeshi Iwasaki, Yoshihiro Katayama, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 1

Alterations of histone modifications in cancer
Maha Saber-Ayad, Wafaa S. Ramadan, Raafat El‐Awady
Elsevier eBooks (2023), pp. 85-172
Closed Access | Times Cited: 3

Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1518-1518
Open Access | Times Cited: 5

Chromatin Dynamics: Chromatin Remodeler, Epigenetic Modification and Diseases
Guofei Cui, Qing Dong, Kexin Gai, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 2

Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
Daniel Osei‐Bordom, Gagandeep Sachdeva, Niki Christou
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 4

Identification of prognostic chromatin-remodeling genes in clear cell renal cell carcinoma
Yujing Yang, Chengyuan Wang, Ningde Wei, et al.
Aging (2020) Vol. 12, Iss. 24, pp. 25614-25642
Open Access | Times Cited: 5

The opportunities and challenges of epigenetic approaches to manage herpes simplex infections
Sarah Saddoris, Luis M. Schang
Expert Review of Anti-infective Therapy (2024), pp. 1-20
Open Access

Page 1 - Next Page

Scroll to top